Targeted isolation of panels of diverse human protective broadly neutralizing antibodies against SARS-like viruses

The emergence of current SARS-CoV-2 variants of concern (VOCs) and potential future spillovers of SARS-like coronaviruses into humans pose a major threat to human health and the global economy(1–7). Development of broadly effective coronavirus vaccines that can mitigate these threats is needed(8,9)....

Descripción completa

Detalles Bibliográficos
Autores principales: He, Wan-ting, Musharrafieh, Rami, Song, Ge, Dueker, Katharina, Tse, Longping V., Martinez, David R., Schäfer, Alexandra, Callaghan, Sean, Yong, Peter, Beutler, Nathan, Torres, Jonathan L., Volk, Reid M., Zhou, Panpan, Yuan, Meng, Liu, Hejun, Anzanello, Fabio, Capozzola, Tazio, Parren, Mara, Garcia, Elijah, Rawlings, Stephen A., Smith, Davey M., Wilson, Ian A., Safonova, Yana, Ward, Andrew B., Rogers, Thomas F., Baric, Ralph S., Gralinski, Lisa E., Burton, Dennis R., Andrabi, Raiees
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845431/
https://www.ncbi.nlm.nih.gov/pubmed/35169804
http://dx.doi.org/10.1101/2021.09.08.459480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845431/
https://www.ncbi.nlm.nih.gov/pubmed/35169804
http://dx.doi.org/10.1101/2021.09.08.459480

Ejemplares similares